|
2022
|
Invention
|
Plasmin-resistant peptides for improved therapeutic index.
The invention provides variants of a ... |
|
|
Invention
|
Plasmin-resistant peptides for improved therapeutic index. The invention provides variants of a p... |
|
2021
|
Invention
|
Chloride salt of tat-nr2b9c. The present invention provides lyophilized formulations of active ag... |
|
|
Invention
|
Therapy for subarachnoid hemorrhage and ischemia.
The application provides data from a clinical ... |
|
|
Invention
|
Lyophilized formulation of tat-nr2b9c with acetylation scavenger.
The present invention provides... |
|
|
Invention
|
Peptide inhibitors of sarsr-cov infection. The invention provides peptides inhibitors for treatin... |
|
|
Invention
|
Inhibition of reperfusion injury with a psd-95 inhibitor.
The peptide inhibitor of PSD-95, Tat-N... |
|
|
Invention
|
Combination treatment of stroke with plasmin-cleavable psd-95 inhibitor and reperfusion.
The pep... |
|
|
Invention
|
Combination treatment of stroke with plasmin-cleavable psd-95 inhibitor and reperfusion. The pept... |
|
|
Invention
|
Inhibition of reperfusion injury with a psd-95 inhibitor. The peptide inhibitor of PSD-95, Tat-NR... |
|
|
Invention
|
Combination therapy for ischemia. The invention provides a combination treatment for ischemia con... |
|
|
Invention
|
Plasmin-resistant peptides for treating stroke and related conditions.
The invention provides va... |
|
|
Invention
|
Plasmin-resistant peptides for treating stroke and related conditions. The invention provides var... |
|
2019
|
Invention
|
Method of reducing injury to mammalian cells.
A method of inhibiting the binding between N-methy... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of stroke; pharmaceuticals for the treatment of neu... |
|
|
Invention
|
Therapy for subarachnoid hemorrhage and ischemia. The application provides data from a clinical t... |
|
|
Invention
|
Prelyophilized, lyophilized and reconstituted formulations comprising tat-nr2b9c with d-amino aci... |
|
|
P/S
|
Pharmaceutical preparations for human and animal use, namely pharmaceuticals for the treatment of... |
|
2018
|
Invention
|
Co-administration of an agent linked to an internalization peptide with an anti-inflammatory.
Th... |
|
2016
|
Invention
|
Co-administration of an agent linked to an internalization peptide with an anti-inflammatory. The... |
|
|
Invention
|
Lyophilized formulation comprising tat-nr2b9c, histidine and trehalose. The present invention pro... |
|
2015
|
Invention
|
Lyophilized formulation of tat-nr2b9c with acetylation scavenger. The present invention provides ... |
|
|
Invention
|
Model systems and treatment regimes for treatment of neurological disease. The invention provides... |
|
2014
|
Invention
|
Methods for treating pain. The invention provides agents useful for treating pain. An exemplary a... |
|
|
Invention
|
Method and compositions for treating stroke with fever.
The invention provides methods of treati... |
|
2013
|
Invention
|
Agents and methods for treating ischemic and other diseases. This invention relates to methods of... |
|
|
Invention
|
Lyophilized formulation of tat-nr2b9c.
The present invention provides lyophilized formulations o... |
|
|
Invention
|
Lyophilized formulation of tat-nr2b9c. The present invention provides lyophilized formulations of... |
|
|
Invention
|
Nd2 peptides and methods of treating neurological disease. The invention is based in part on iden... |
|
2012
|
Invention
|
Treating stroke and other diseases without inhibiting n-type calcium channels. The invention prov... |
|
|
Invention
|
Agents and methods for treating ischemic and other diseases. This invention relates to compounds ... |
|
2011
|
Invention
|
Treatment of penetrative injury to the brain. The invention provides methods of treatment or prop... |
